Pfizer: Depressive Disorder, Major trials
The registry lists 53 Depressive Disorder, Major studies with Pfizer as lead sponsor. 0 are open to participants now and 27 have results posted.
Phase 1 5Phase 2 6Phase 3 27Phase 4 8No phase 7(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Non-interventional, Retrospective Cohort Study to Explore Antidepressant Treatment in KoreaCompletedNCT04446039Results posted
- Korean Post Marketing Surveillance to Observe Effectiveness and Safety of PRISTIQCompletedNCT02548949Results posted
- Study Evaluating Desvenlafaxine Succinate Sustained-Release (DVS SR) in Adult Outpatients With Major Depressive Disorder (MDD)CompletedNCT01432457Phase 4Results posted
- A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDDCompletedNCT01372150Phase 3Results posted
- A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDDCompletedNCT01371734Phase 3Results posted
- A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children and Adolescents With MDDCompletedNCT01371721Phase 3Results posted
- A 6-Month Extension Study To The B2061032 Study To Evaluate The Safety, Tolerability, And Efficacy Of DVS SR In The Treatment Of Child And Adolescent Outpatients With MDDCompletedNCT01371708Phase 3Results posted
- Desvenlafaxine Succinate (Pristiq): Postmarketing Surveillance Study Among Filipino PatientsTerminatedNCT01353963Results posted
- Phase 1 Study To Test the Bioequivalence Between Two 25 mg Tablets vs. One 50 mg Tablet Under Fast/Fed Condition and Evaluate Food Effect of Desvenlafaxine Succinate Sustained Release (DVS SR)CompletedNCT01190514Phase 1Results posted
- Study Evaluating Desvenlafaxine Succinate Sustained-Release (DVS SR) In The Treatment Of Peri- And Postmenopausal Women With Major Depressive Disorder (DVS 3364)CompletedNCT01121484Phase 4Results posted
- A Study Of The Efficacy And Safety Of CP-601,927 Augmentation Of Antidepressant Therapy In Major DepressionTerminatedNCT01098240Phase 2Results posted
- Study Comparing Discontinuation Symptoms Of DVS SR In Subjects With Major Depressive Disorder (MDD)CompletedNCT01056289Phase 4Results posted
- Study Evaluating the Effect of Desvenlafaxine on the Pharmacokinetics of MidazolamCompletedNCT00952653Phase 4Results posted
- Relapse Prevention Study Of Desvenlafaxine Succinate Sustained Release In Outpatients With Major Depressive DisorderCompletedNCT00887224Phase 3Results posted
- Study Evaluating Desvenlafaxine Succinate Sustained Release In Adults With Major Depressive DisorderCompletedNCT00863798Phase 3Results posted
- Study Evaluating Long-Term Safety of Desvenlafaxine Succinate Sustained Release With Japanese Adult Subjects in Major Depressive Disorder (MDD)CompletedNCT00831415Phase 3Results posted
- Study Evaluating Desvenlafaxine Succinate Sustained Release In Outpatients With Major Depressive DisorderCompletedNCT00824291Phase 3Results posted
- Study Evaluating Desvenlafaxine Succinate Sustained Release (DVS SR) in the Treatment of Major Depressive DisorderCompletedNCT00798707Phase 3Results posted
- Study Comparing Remission Rates, in Patients With Major Depressive Disorder (MDD)CompletedNCT00770289Results posted
- Study Evaluating Desvenlafaxine Succinate Sustained-Release Tablets (DVS SR) In The Treatment Of Child and Adolescent Outpatients With Major Depressive DisorderCompletedNCT00669110Phase 2Results posted
- Study Evaluating Desvenlafaxine Succinate Sustained-Release (DVS SR) In The Treatment Of Child And Adolescent Outpatients With Major Depressive DisorderCompletedNCT00619619Phase 2Results posted
- Study Comparing the Efficacy of Venlafaxine XR Vs. SSRIs and Conventional Antidepressants in Depressed PatientsCompletedNCT00474708Phase 4Results posted
- Paroxetine-referenced Study Evaluating Three Doses of DVS SR in Outpatients With MDDCompletedNCT00445679Phase 3Results posted
- Study Evaluating Desvenlafaxine Succinate Sustained Release (DVS SR) vs. Escitalopram in Postmenopausal WomenCompletedNCT00406640Phase 3Results posted
- Open-Label, Randomized Study Evaluating Treatment With Venlafaxine Extended-Release Plus Dialogues Time to Talk ProgramCompletedNCT00401726Phase 4Results posted
- Study Evaluating Desvenlafaxine Succinate Sustained Release (DVS SR) In The Treatment Of Major Depressive DisorderCompletedNCT00384033Phase 3Results posted
- Study Evaluating Desvenlafaxine Succinate Sustained Release (DVS SR) Versus Placebo in Peri- and Postmenopausal WomenCompletedNCT00369343Phase 3Results posted
- Pharmacokinetics and Safety of Desvenlafaxine in Korean Healthy Subjects Following Single and Multiple Oral Doses of Desvenlafaxine Succinate Sustained Release TabletCompletedNCT01443208Phase 1
- A Phase 1 Study To Investigate The Pharmacokinetics, Safety And Tolerability Of CP-601,927 In Healthy Japanese SubjectsWithdrawnNCT01396135Phase 1
- Long-Term Safety Of DVS-233 SR In Patients With Major Depressive DisorderCompletedNCT01309542Phase 3
- Retrospective Study Evaluating The Current Utilization Of Desvenlafaxine Succinate Sustained-Release (Pristiq) Among Psychiatrists And Primary Care Physicians In The Treatment Of Patients With Major Depressive DisorderCompletedNCT01221935
- Study Evaluating Effexor XR in Chinese Subjects With Major Depressive DisorderWithdrawnNCT00878748Phase 4
- Study Evaluating the Potential of DVS SR to Inhibit the CYP2D6 PathwayCompletedNCT00456898Phase 1
- Study Evaluating DVS-233 for Treatment of Outpatients With Major Depressive DisorderCompletedNCT00452595Phase 3
- Study Evalutating the Pharmacokinetics (PK) and Safety of a Single Dose of Desvenlafaxine Sustained Release (DVS SR)CompletedNCT00440427Phase 1
- Study for Evaluating Different Methods of Measuring Depression Treatment ResponseCompletedNCT00406952Not applicable
- Study Evaluating the Effects of DVS SR and Duloxetine on the Pharmacokinetics of Desipramine in Healthy SubjectsCompletedNCT00366652Phase 3
- Study Evaluating the Pharmacokinetics of Venlafaxine ER and Desvenlafaxine SR in Healthy SubjectsCompletedNCT00329186Phase 3
- Study Evaluating the Effects of DVS SR and Paroxetine on the Pharmacokinetics of Desipramine in Healthy SubjectsCompletedNCT00329147Phase 3
- Study Evaluating the Efficacy and Safety of Desvenlafaxine Tablets in Adult Outpatients With Major Depressive DisorderCompletedNCT00300378Phase 3
- Study Evaluating Desvenlafaxine Sustained-Release (DVS-SR) in Adult Outpatients With Major Depressive DisorderCompletedNCT00277823Phase 3
- A Research Study to Compare the Treatments of a Combination of Elzasonan With Zoloft, to Zoloft Alone, or Placebo in People With Major Depressive Disorder (MDD)CompletedNCT00275197Phase 2
- Study Evaluating DVS-233 SR in Elderly Outpatients With Major Depressive DisorderCompletedNCT00242229Not applicable
- The Antidepressant Effects Of The NMDA Antagonist, CP-101,606, In Patients With MDDCompletedNCT00163059Phase 2
- Multicentre Trial to Evaluate the Safety and Efficacy of CP-316,311 in Major Depressive DisorderTerminatedNCT00143091Phase 2
- Study Evaluating DVS-233 SR in Adult Outpatients With Major Depressive DisorderCompletedNCT00092911Phase 3
- Study Evaluating DVS-233 SR And Venlafaxine ER In Adult Outpatients With Major Depressive DisorderCompletedNCT00090649Phase 3
- Study Evaluating DVS-233 SR and Venlafaxine ER in Adult Outpatients With Major Depressive DisorderCompletedNCT00087737Phase 3
- Study Evaluating DVS-233 SR In Adult Outpatients With Major Depressive DisorderCompletedNCT00075257Phase 3
- Study Evaluating DVS-233 SR In Adult Outpatients With Major Depressive DisorderCompletedNCT00073762Phase 3
- Study Evaluating DVS-233 SR In Adult Outpatients With Major Depressive DisorderCompletedNCT00072774Phase 3
- Study Evaluating DVS-233 in Adult Outpatients With Major Depressive DisorderCompletedNCT00063206Phase 3
- Study Evaluating Venlafaxine ER in Recurrent DepressionCompletedNCT00046020Phase 4